We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$119M
Cap. Flow
+$6.18M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.68%
Holding
567
New
17
Increased
150
Reduced
169
Closed
110

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$4.08M
2
VZ icon
Verizon
VZ
+$3.9M
3
OXY icon
Occidental Petroleum
OXY
+$2.83M
4
ASML icon
ASML
ASML
+$2.77M
5
BA icon
Boeing
BA
+$2.47M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.98M
2
GMED icon
Globus Medical
GMED
+$2.48M
3
NOV icon
NOV
NOV
+$2.12M
4
AGN
Allergan Inc
AGN
+$2.02M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 11.84%
3 Industrials 11.53%
4 Financials 10.85%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
26
Alphabet (Google) Class C
GOOG
$3.9T
$21M 0.93%
725,025
+6,502
+0.9% +$176K
GILD icon
27
Gilead Sciences
GILD
$161B
$20.8M 0.92%
251,071
+1,399
+0.6% +$109K
AGN
28
DELISTED
Allergan Inc
AGN
$20.7M 0.91%
122,372
-13,005
-10% -$2.02M
BA icon
29
Boeing
BA
$165B
$20.6M 0.91%
161,723
+18,934
+13% +$2.47M
ECL icon
30
Ecolab
ECL
$75.6B
$20.5M 0.9%
184,008
-875
-0.5% -$93.8K
CAT icon
31
Caterpillar
CAT
$409B
$19.8M 0.87%
182,184
-4,072
-2% -$427K
MET icon
32
MetLife
MET
$61B
$19.7M 0.87%
398,203
-1,076
-0.3% -$50.4K
VZ icon
33
Verizon
VZ
$194B
$19.7M 0.87%
402,700
+80,588
+25% +$3.9M
HON icon
34
Honeywell
HON
$77B
$19.5M 0.86%
233,120
+830
+0.4% +$69.4K
EMC
35
DELISTED
EMC CORPORATION
EMC
$18.8M 0.83%
715,109
-5,572
-0.8% -$147K
NGG icon
36
National Grid
NGG
$81.9B
$18.7M 0.83%
260,873
-5,616
-2% -$389K
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$18.6M 0.82%
95,145
-4,783
-5% -$909K
DD
38
DELISTED
Du Pont De Nemours E I
DD
$17.4M 0.77%
279,708
+1,744
+0.6% +$112K
MRK icon
39
Merck
MRK
$324B
$17.2M 0.76%
311,494
+2,753
+0.9% +$150K
MMM icon
40
3M
MMM
$89B
$16.7M 0.74%
139,474
+425
+0.3% +$49.9K
EEM icon
41
iShares MSCI Emerging Markets ETF
EEM
$28B
$15.8M 0.7%
365,853
-30,907
-8% -$1.31M
UN
42
DELISTED
Unilever NV New York Registry Shares
UN
$15.6M 0.69%
357,453
+3,366
+1% +$144K
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.07T
$15.6M 0.69%
123,376
-155
-0.1% -$19.6K
ABBV icon
44
AbbVie
ABBV
$458B
$15M 0.66%
265,171
-17,038
-6% -$894K
VWO icon
45
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$14.5M 0.64%
335,536
-6,630
-2% -$279K
ABT icon
46
Abbott
ABT
$180B
$14.3M 0.63%
349,749
+39,552
+13% +$1.55M
PM icon
47
Philip Morris
PM
$301B
$14.3M 0.63%
169,456
-13,867
-8% -$1.19M
EFA icon
48
iShares MSCI EAFE ETF
EFA
$76.4B
$14.2M 0.63%
207,072
-997
-0.5% -$68.3K
WFC icon
49
Wells Fargo
WFC
$261B
$13.7M 0.61%
261,293
-2,165
-0.8% -$109K
PFE icon
50
Pfizer
PFE
$140B
$13.6M 0.6%
481,656
+12,541
+3% +$357K

Similar funds

Gofen & Glossberg's Q2 2014 Portfolio in Review

As of Q2 2014, Gofen & Glossberg held 567 positions worth $2.26B, up 5.5% from $2.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q2 2014 filing shows 17 new, 150 increased, 169 reduced and 110 closed positions. Its largest new stake was Splunk Inc: 35,720 shares worth $1.98M. The largest sale was Vodafone, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q2 2014 buy was Splunk Inc: 35,720 shares worth $1.98M.
  • Gofen & Glossberg added most to Perrigo in Q2 2014, an estimated $4.08M increase.
  • Gofen & Glossberg's biggest Q2 2014 reduction was Vodafone, cutting an estimated $2.98M.
  • Gofen & Glossberg fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $722K.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.26B portfolio in Q2 2014.
  • Gofen & Glossberg opened 17 new positions and closed 110 in Q2 2014.
  • Gofen & Glossberg's portfolio value rose 5.5% quarter-over-quarter to $2.26B.

Based on Gofen & Glossberg's 13F filing for Q2 2014, filed 15 Jul 2014.